Viz.ai Launches Viz Pulmonary™ Suite: AI-Powered Workflows for COPD, Lung Nodules, and PE

Why It Matters

By accelerating diagnosis and ensuring follow‑up, the suite can reduce mortality, readmissions, and revenue loss from patient leakage, reshaping pulmonary care economics.

Key Takeaways

• Viz Pulmonary Suite integrates AI for COPD, nodules, PE.
• Study cut PE treatment time from 1.75 to 0.56 days.
• Addresses 71% missed lung nodules and 79% missed incidental PE.
• Reduces health system leakage affecting 55‑65% of referrals.
• Improves 30‑day COPD readmission monitoring.

Pulse Analysis

The pulmonary care pathway has long suffered from fragmentation, with patients shuttling between emergency departments, imaging suites, and acute‑care wards. Critical findings such as incidental emboli or suspicious nodules often disappear in the hand‑off, leading to delayed or absent treatment. Viz.ai’s new Viz Pulmonary™ Suite embeds artificial‑intelligence algorithms directly into existing electronic health‑record workflows, delivering real‑time alerts and guideline‑based recommendations. By creating a single, clinician‑in‑the‑loop interface, the platform promises to close the “coordination gap” that has hampered pulmonary management for years.

Early clinical evidence underscores the suite’s potential. In a single‑center trial, the Viz PE tool trimmed average time to therapy from 1.75 days to just 0.56 days and was associated with lower in‑hospital mortality among high‑risk patients. The solution also targets systemic inefficiencies: it aims to recapture the 55‑65% of referrals lost to health‑system leakage and to ensure follow‑up for the 71% of significant lung nodules and 79% of incidental pulmonary emboli that traditionally go unnoticed. COPD readmission rates, which hover near 50% within 30 days, are likewise monitored through automated alerts.

Viz.ai’s integrated approach reflects a broader shift toward AI‑driven care coordination across the health‑tech landscape. By automating guideline surfacing and providing concise patient summaries, the suite reduces administrative burden while improving clinical consistency, a combination that can translate into cost savings and better patient outcomes. As payers and providers increasingly demand value‑based metrics, tools that retain patients within a health system and accelerate treatment decisions are likely to gain rapid adoption, positioning Viz.ai as a key player in the next wave of digital pulmonary care.